Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.
Free White Paper
As a guest to ChinaBio® Today, you have access to summaries of over 2500 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
3SBio Pays $85 Million to Acquire Zhejiang Washeng Pharma | July 24, 2015
Jiangsu Hengrui to Build $137 Million Biologic Drug Facility | July 16, 2015WuXi Healthcare Ventures Files for $250 Million China-US Fund | July 15, 2015
WuXi PharmaTech Raises $80 Million for Manufacturing Subsidiary | July 10, 2015
Oramed Pharma Signs $50 Million Diabetes Deal with Sinopharm | July 7, 2015
3SBio Acquires Global Rights to Apexigen RA Drug | June 22, 2015>> See all top stories...
ChinaBio® in the News